Neuramis Lidocaine HA Filler 1-Needle

(1 customer review)

- Bulk Discount From 5 PCS
- Get 5% extra discount by using WISE or Bank Transfer

Neuramis Lidocaine presents an innovative dermal HA filler containing 20 mg/ml of cross-linked hyaluronic acid and 0.3% lidocaine, designed specifically for correction of skin imperfections with clinical efficacy sustained for 9 months. Cross-linked HA structure guarantees longer effect duration, while its even distribution in the epidermis yields natural-looking results. Clinically validated hydration persists for 72 hours post-treatment, supported by its low swelling index (Grade 1) for minimal downtime.

$24.50

Quantity discounts
Quantity Discount Price
5-93%$23.77
10-195%$23.28
20-Unlimited8%$22.54

Neuramis Lidocaine HA Filler (1 Needle) — Medytox SHAPE™ HA Filler for Moderate Wrinkles

HA Concentration
20 mg/mL
Lidocaine
0.3% premixed
Pack
1 × 1.0 mL syringe + 1 × 27G UTW needle
Needles
1 × 27G ½” Ultra Thin Wall (UTW)
Depth
Mid dermis
Duration
6–12 months
Indications
Moderate wrinkles · Lip border · Perioral · Fine-to-mid lines
Technology
SHAPE™ — Korean-manufactured · Standard 2–25 °C storage

What it is

Neuramis Lidocaine HA Filler (1-needle version) is the standard-density tier of Medytox’s SHAPE™ dermal filler range — formulated for moderate facial wrinkles, lip border definition, and superficial perioral correction. The SHAPE™ 2-step cross-linking with residual BDDE below 0.4 PPM ensures safety and integration. This 1-needle pack includes a single 27G UTW (Ultra Thin Wall) needle.

How SHAPE™ Technology works

SHAPE™ (Stabilized Hyaluronic Acid & Purification Enhancement) is Medytox's patented manufacturing process used across the Neuramis range. Two engineering decisions distinguish it from standard BDDE cross-linking:

Pillar 1
2-Step Cross-Linking

Traditional process: BDDE and HA react in a single step. Result: significant unreacted BDDE remains, requiring extensive post-purification.

SHAPE process: A first cross-linking reaction is followed by a second cross-linking pass on the under-reacted HA chains. More BDDE is consumed in reactions; less is left as residue. The gel network is also denser and more stable, contributing to longer in-vivo duration.

Pillar 2
Enhanced Purification

Multiple dialysis cycles remove any remaining unreacted BDDE before final sterilization, followed by additional pre-sterilization purification.

Result: residual BDDE < 0.4 PPM — five times stricter than the EU regulatory ceiling of < 2 PPM. Endotoxin levels also held to ultra-low specification.

Cross-linking technology Manufacturer Core mechanism Residual BDDE
SHAPE™ (this product) Medytox (Korea) 2-step cross-linking + enhanced purification < 0.4 PPM
NASHA® Galderma (Sweden) Biphasic particle cross-linking Industry standard
Vycross® Allergan (USA) High + low MW HA blend cross-linking Industry standard
CPM® Merz (Germany) Polydensified cohesive matrix Industry standard
Hy-BRID GENOSS (Korea) Uniform-particle HA Industry standard

EU MDR ceiling for residual BDDE in dermal fillers is < 2 PPM. SHAPE™ operates 5× stricter than the regulatory floor. Comparison based on manufacturer-published technical data.

Why this matters clinically

Lower residual BDDE reduces the risk of inflammatory and hypersensitivity reactions. Denser cross-linking from the 2-step process extends in-vivo durability. Medytox is also the manufacturer of Neuronox botulinum toxin — the same Korean GMP infrastructure produces the Neuramis range.

Technical specifications

Detail for clinical, regulatory, and shipping reference. Headline figures shown in the panel above.

Pack Configuration 1 syringe + 1 needle (economy pack)
Needle Type 27G ½” UTW (Ultra Thin Wall)
BDDE Residue <0.4 PPM
HA Source Bacterial fermentation, non-animal origin
Cross-linking SHAPE™ 2-step process + enhanced purification
Manufacturer Medytox Inc.
Origin South Korea
Certifications CE marked · KFDA · GMP certified
Storage 2–25 °C · do not freeze · protect from direct sunlight
Shelf life 24 months unopened (verify lot label)
Reversibility Dissolvable with hyaluronidase if needed
Intended use Licensed medical professionals only

FAQ

How is the standard Neuramis HA Filler different from Deep and Volume?+

All three use Medytox SHAPE™ technology and 20 mg/mL HA + 0.3% lidocaine. The differentiator is viscoelasticity and target depth. Standard HA Filler (lowest density, mid-dermis) — moderate facial wrinkles, lip border, perioral fine lines (6–12 month duration). Deep (medium density, mid-to-deep dermis) — NLF, marionettes, deep wrinkles, lip body (9–12 month duration). Volume (highest density, subcutaneous) — cheek/chin/nose structural volume (12–18 month duration).

How long does this product last?+

Duration is 6–12 months depending on injection site, patient metabolism, and lifestyle. Mobile facial zones (lips, perioral) typically resorb faster than static zones (cheek, temple). Individual hyaluronidase activity also influences longevity.

What’s the storage requirement?+

Standard HA filler storage at 2–25 °C (room temperature acceptable). Do not freeze. Protect from direct sunlight. No cold-chain shipping required (this is not a botulinum toxin). 24-month shelf life unopened; verify lot label before use.

Where to buy wholesale and how to verify authenticity?+

Wholesale through MJS Medicals for licensed healthcare professionals. To verify authenticity: (1) intact tamper-evident sterile seal; (2) batch number with manufacturer traceability label; (3) HA concentration matches 20 mg/mL on packaging; (4) Korean origin marking visible; (5) CE / KFDA certification visible on box.

Who is qualified to inject?+

Licensed physicians, dermatologists, plastic surgeons, and aesthetic practitioners with HA filler-specific training only. Buyers self-certify professional status at checkout.

Safety

This product-specific: Mid-dermal placement — careful depth control to avoid Tyndall effect (bluish discoloration from superficial placement). Standard vascular precautions for perioral and lip-border zones. The 27G UTW needle reduces injection trauma in delicate areas.

Prescription medical device. Contraindicated in known hypersensitivity to HA, lidocaine, or Gram-positive bacterial proteins; severe allergies / anaphylaxis history; pregnancy / breastfeeding; autoimmune disorders; active local infection; and concurrent anticoagulant therapy. Aspirate before injection; keep hyaluronidase on hand for reversal.

→ Full Dermal Filler Safety Information

Last reviewed: May 2026 · Source verification: Manufacturer official documentation · South Korea
5
1 review
1
0
0
0
0

1 review for Neuramis Lidocaine HA Filler 1-Needle

Clear filters
    Aesthetic
    2025-07-18
    The Neuramis Lidocaine introduced by MJS has been a lifesaver for our clinic! Patients show almost no redness or swelling after treatment, and they can resume social activities the very next day. I especially love its smooth injection feel—it's so precise for tear trough filler. Compared to other brands, MJS's supply reliability is truly unmatched—never any delays for scheduled appointments.
Add a review

Your email address will not be published. Required fields are marked *

Interested in Wholesale?

Contact Us Now

Be The First To Know About Wholesale, Exclusive Sales & More

Interested in Wholesale?

Contact Us Now

Be The First To Know About Wholesale, Exclusive Sales & More